Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study Assessing the Effect of Tildrakizumab in Vitiligo

NCT04971200 is registered in ClinicalTrials.gov with Premier Specialists, Australia as lead sponsor.

NCT NCT04971200
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04971200 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study Assessing the Effect of Tildrakizumab in Vitiligo
Lead sponsor
Premier Specialists, Australia
Phase
Phase 1
Overall status
Completed
Start date
September 16, 2021
Completion date
November 10, 2024
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biologic, hypopigmentation, pigmentation disorder, skin and connective tissue diseases, skin diseases, vitiligo